Thank you for your interest in PharmSource’s white paper, The U.S. Foreign Corrupt Practices Act (FCPA): How to Minimize Your Risk. This incisive resource provides guidelines on how to establish a strong FCPA compliance program to minimize corruption risk for companies doing business throughout the world.
This white paper includes detailed information on:
- Industry-specific implications of current FCPA regulations.
- Essential elements of a strong FCPA compliance program for those in the bio/pharma industry.
- Comprehensive steps to implement a solid FCPA compliance program.
- Enforcement of anti-corruption business practices in emerging markets.
- Mechanisms to avoid compliance pitfalls despite global and economic challenges.
Since the U.S. is increasing the number of investigations of FCPA and financial fraud violations in the pharmaceutical sector, this timely publication is a critical first step in understanding FCPA practices while conducting business in emerging markets.
PharmSource offers you a unique opportunity to download The U.S. Foreign Corrupt Practices Act (FCPA): How to Minimize Your Risk white paper for free.
Simply complete this short form and download this white paper now!
